These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 10451808

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation.
    Chan CM, Martin LA, Johnston SR, Ali S, Dowsett M.
    J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):333-41. PubMed ID: 12361723
    [Abstract] [Full Text] [Related]

  • 48. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
    Osborne CK, Boldt DH, Estrada P.
    Cancer Res; 1984 Apr; 44(4):1433-9. PubMed ID: 6704960
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
    Atanaskova N, Keshamouni VG, Krueger JS, Schwartz JA, Miller F, Reddy KB.
    Oncogene; 2002 Jun 06; 21(25):4000-8. PubMed ID: 12037682
    [Abstract] [Full Text] [Related]

  • 53. Dynamic interactions between the extracellular matrix and estrogen activity in progression of ER+ breast cancer.
    Jallow F, O'Leary KA, Rugowski DE, Guerrero JF, Ponik SM, Schuler LA.
    Oncogene; 2019 Oct 06; 38(43):6913-6925. PubMed ID: 31406251
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Selective estrogen receptor (ER) modulators differentially regulate phospholipase D catalytic activity in ER-negative breast cancer cells.
    Eisen SF, Brown HA.
    Mol Pharmacol; 2002 Oct 06; 62(4):911-20. PubMed ID: 12237338
    [Abstract] [Full Text] [Related]

  • 56. Cell cycle analysis of estrogen stimulation and antiestrogen inhibition of growth of the human breast cancer cell line MCF-7.
    Lykkesfeldt AE, Larsen JK, Christensen IJ.
    Breast Cancer Res Treat; 1986 Oct 06; 7 Suppl():S83-90. PubMed ID: 3742066
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. [Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method].
    Kurebayashi J, Horiuchi R, Nakamura T, Iino Y, Ishida T, Takigawa H, Izuo M.
    Nihon Naibunpi Gakkai Zasshi; 1987 Nov 20; 63(11):1351-63. PubMed ID: 2965035
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.